EyePoint, Inc. EYPT 深 沪
已收盘 05-08 16:00:00 美东时间
13.66
+0.250
+1.86%
华盛通- 最 高13.75
- 今 开13.35
- 成交量 66.15万股
- 最 低 13.29
- 昨 收 13.41
- 总市值 11.45亿
- 52周最高 19.11
- 市盈率 静 --
- 换手率 0.79%
- 52周最低 5.455
- 委 比 -11.20%
- 总股本 8379.52万
- 历史最高 39.40
- 量 比 0.66
- 振 幅 3.43%
- 历史最低 2.19
- 每 手 1
- 风险率 3.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
EyePoint Pharma Bets on DURAVYU Amid Mounting Losses
Eyepoint Pharma (($EYPT)) has held its Q1 earnings call. Read on for the main h...
05-08 10:20
RBC Capital Maintains Outperform on EyePoint, Lowers Price Target to $37
RBC Capital analyst Lisa Walter maintains EyePoint (NASDAQ:EYPT) with a Outperform and lowers the price target from $39 to $37.
05-08 01:36
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
新浪财经ESG：EyePoint Pharmaceuticals Inc. MSCI（明晟）ESG评级调降至BB
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
05-06 07:00
Ocular Therapeutix misses Q1 street views
Ocular Therapeutix press release (OCUL): Q1 GAAP EPS of -$0.40 misses by $0.07. Revenue of $10.8M (+0.9% Y/Y) misses by $1.9M. Cash balance of $666.7 million as of March 31, 2026, with expected runway...
05-05 19:12
Insiders Dump Shares in Global-e, EyePoint, Immunovant, Nerdy, Argan
Insiders have been trading these 5 stocks: (($GLBE)), (($EYPT)), (($IMVT)), (($...
04-25 21:01
新浪财经ESG：EyePoint Pharmaceuticals Inc. MSCI（明晟）ESG评级调降至BBB
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:19
EyePoint sues Ocular over claims related to lead asset
EyePoint (EYPT) has filed a lawsuit against Ocular Therapeutix (OCUL) in a Massachusetts federal court, alleging that its rival eye drug developer made false claims regarding its lead candidate, Durav...
03-21 22:23
